Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.

Alcidion Group’s fair value price target is held steady at A$0.14667, with the latest work keeping it aligned with the prior A$0.15 view. This reflects a sector backdrop where analysts are split, with some pointing to peers that still support premium valuations if execution holds, while others remain cautious on growth assumptions and risk. Read on to see how you can track this evolving narrative and what to watch as new information comes through.

Stay updated as the Fair Value for Alcidion Group shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Alcidion Group.

What Wall Street Has Been Saying

🐂 Bullish Takeaways

Deutsche Bank upgraded Alcon, which signals some confidence that the company can execute on its current plans and that the stock’s risk and reward trade off remains acceptable at recent levels. BTIG highlights that Alcon has other products and existing markets to focus on after the Staar Surgical transaction was voted down, which supports a view that management has options for allocating attention and resources.

🐻 Bearish Takeaways

Stifel moved Alcon to Hold from Buy and cut its price target to US$80 from US$85, citing a mixed Unity system survey that tempered conviction in higher system installation outcomes and made Street sales expectations for 2026 look harder to achieve without more Unity contribution. Research around the Staar Surgical deal, including BTIG’s Neutral stance on Staar, underlines that M&A driven growth for Alcon can come with deal risk and shareholder pushback, which can weigh on how investors think about execution and timing.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!ASX:ALC 1-Year Stock Price Chart

We've flagged 2 risks for Alcidion Group. See which could impact your investment.

How This Changes the Fair Value For Alcidion Group

Fair value is held at A$0.14667, aligned with the prior estimate. Long term annual revenue growth expectation is effectively steady at 11.83%. Projected net profit margin remains about 9.35%. Forward P/E multiple is adjusted slightly from 46.50x to 46.48x. Discount rate is set at 7.99%, compared with the prior 8.01%.

Never Miss an Update: Follow The Narrative

Narratives connect Alcidion Group’s business story to its earnings forecasts and fair value, so you can see how new contracts, markets, and risks feed into the bigger picture. They update over time as fresh information comes through, keeping the investment case grounded in current data.

Story Continues

Head over to the Simply Wall St Community and follow the Narrative on Alcidion Group to stay up to date on:

How rising annual recurring revenue from multi year modular contracts and a strong UK base ties into the shift toward digital healthcare workflows. What the Miya Precision platform, land and expand contract extensions, and new regions such as Canada, Saudi Arabia, and the UAE mean for recurring earnings. Key risks around reliance on a few large UK contracts, possible delays in customer funding decisions, and higher costs as Alcidion expands into new markets and meets evolving regulations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ALC.AX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments